Sopharma AD
Sopharma AD, a leading pharmaceutical company headquartered in Bulgaria (BG), has been a significant player in the healthcare industry since its establishment in 1996. With a strong presence in Eastern Europe and beyond, Sopharma focuses on the development, production, and distribution of a wide range of medicinal products, including generic drugs, over-the-counter medications, and active pharmaceutical ingredients. Renowned for its commitment to quality and innovation, Sopharma AD has achieved notable milestones, including the expansion of its manufacturing capabilities and the introduction of several patented formulations. The company’s core products are distinguished by their efficacy and affordability, catering to diverse therapeutic areas. As a prominent entity in the pharmaceutical sector, Sopharma continues to enhance its market position through strategic partnerships and a robust portfolio, contributing to improved healthcare outcomes across its operational regions.
DitchCarbon Score
How does Sopharma AD's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sopharma AD's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sopharma AD's reported carbon emissions
Sopharma AD, headquartered in Bulgaria (BG), currently does not have available data on carbon emissions, as no specific emissions figures have been reported. Consequently, there are no defined reduction targets or climate commitments outlined by the company at this time. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This includes setting science-based targets and committing to reducing their carbon footprints across various scopes of emissions. As the industry evolves, it is anticipated that Sopharma AD may adopt similar initiatives to enhance its environmental responsibility and align with global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sopharma AD is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
